바이오맥스
바이오맥스's KOBDi Score is 16.76 as of Sep 2026, up 0.16 points since Apr 2025; it rose in 1 of the 12 monthly updates and never fell. As of Sep 2026 it is ahead of about 20% of companies in its industry, against 20% in Aug 2026 and 25% in Apr 2025. Its strongest position was 26% (May 2025) and its weakest 20% (Sep 2026).
A year earlier, in Aug 2025, its score was 16.60 and it was ahead of about 25% of companies in its industry.
| Sep 2026 | 16.76 | ahead of 20% |
| Aug 2026 | 16.76 | ahead of 20% |
| Jul 2026 | 16.76 | ahead of 20% |
| Jun 2026 | 16.76 | ahead of 20% |
| May 2026 | 16.76 | ahead of 20% |
| Apr 2026 | 16.76 | ahead of 20% |
| Mar 2026 | 16.76 | ahead of 21% |
| Feb 2026 | 16.76 | ahead of 24% |
| Dec 2025 | 16.60 | ahead of 24% |
| Aug 2025 | 16.60 | ahead of 25% |
| Jul 2025 | 16.60 | ahead of 25% |
| May 2025 | 16.60 | ahead of 26% |
| Apr 2025 | 16.60 | ahead of 25% |
Where is 바이오맥스 located?
바이오맥스 is registered at 경기 포천시 화현면 달인동로1길, South Korea (postal code 11123).
What industry is 바이오맥스 in?
바이오맥스 belongs to Manufacturing › Agrochemicals › Manufacturing of biological sterilization, pesticides and plant protection agents.
How many employees does 바이오맥스 have?
바이오맥스 has 1–4 employees.
What is 바이오맥스's KOBDi Score?
16.76 as of September 2026, ahead of about 20% of companies in its industry.
Who are 바이오맥스's competitors?
Similar companies include 그린양행, Dalmatian Pyrethrum and 내츄럴사이언스.

